The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases.

scientific article published in September 2014

The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID25191779

P50authorHubertus HimmerichQ47421869
Frank Martin SchmidtQ48202494
P2093author name stringKenneth C Kirkby
P433issue3
P921main subjecttreatment-resistant depressionQ7836891
TNFQ18032037
P304page(s)288-290
P577publication date2014-09-01
P1433published inPsychiatria DanubinaQ26853899
P1476titleThe TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases
P478volume26

Reverse relations

cites work (P2860)
Q59796810Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression
Q64241077Cytokine Research in Depression: Principles, Challenges, and Open Questions
Q64250176Genetic risk factors for eating disorders: an update and insights into pathophysiology
Q37310533Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.
Q57469273Medial Forebrain Bundle Deep Brain Stimulation Reverses Anhedonic-Like Behavior in a Chronic Model of Depression: Importance of BDNF and Inflammatory Cytokines
Q48051448Molecular serum signature of treatment resistant depression
Q59792260Serum Markers of Inflammation Mediate the Positive Association Between Neuroticism and Depression
Q26774472The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their Therapy
Q64245282The Influence of Antidepressants on the Immune System
Q55163955The role of neuroinflammation and neurovascular dysfunction in major depressive disorder.

Search more.